This inventor holds 13 USPTO granted patents and 7 published patent applications and 2 EPO patents. Top assignees: University of Florida Research Foundation Inc., The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2014-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Astin, MN (US) (2021)
- Austin, MN (US) (2018 - 2022)
- Gainesville, FL (US) (2014 - 2024)
Company Filing History:
12 out of 3,056 
1 out of 3,697 
Years Active: 2014-2026
Title: **George Vladimirovich Aslanidi: A Pioneer in Genetic Engineering and rAAV Vector Innovations**
Introduction
George Vladimirovich Aslanidi, based in Austin, MN, is a distinguished inventor and researcher known for his significant contributions to genetic engineering. With an impressive portfolio of 11 patents, Aslanidi has focused on enhancing the efficiency of rAAV (recombinant adeno-associated virus) vectors, which are critical in gene therapy applications.
Latest Patents
Among his latest innovations is the patent for "High-transduction-efficiency rAAV vectors, compositions, and methods of use." This invention offers a groundbreaking approach by providing AAV capsid proteins that comprise modifications to surface-exposed lysine, serine, threonine, and/or tyrosine residues in the VP3 region. The patent also describes rAAV virions containing these modified capsid proteins and related nucleic acid molecules and vectors. The advantage of his rAAV vectors and virions lies in their improved transduction efficiency across various cells, tissues, and organs compared to wild-type rAAV vectors.
Career Highlights
George Aslanidi works with the University of Florida Research Foundation, Incorporated, where he applies his expertise to advance the field of gene therapies. His innovative work has not only contributed to academic research but also has practical implications for improving the effectiveness of gene delivery systems in medical treatments.
Collaborations
Throughout his career, Aslanidi has collaborated with notable colleagues in the research field, including Arun Srivastava and Kim M Van Vliet. These partnerships have fostered a rich environment for innovation and have significantly impacted the advancement of genetic research.
Conclusion
George Vladimirovich Aslanidi's contributions to the field of genetic engineering, particularly through his patented innovations in rAAV vectors, highlight the importance of ongoing research and development in biomedicine. His work continues to pave the way for improved gene therapy techniques, showcasing the vital role of inventors in advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile